Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Nature Communications|November 1, 2017
Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusionsMartin G Dalin, Nora Katabi, Marta Persson, et al.Immunity|October 26, 2022
Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancerBriana G Nixon, Fengshen Kuo, LiangLiang Ji, et al.Nature Communications|August 19, 2020
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in miceRouven Hoefflin, Sabine Harlander, Silvia Schäfer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease ProgressionJulian Marcon, Renzo G DiNatale, Alejandro Sanchez, et al.Science (New York, N.Y.)|May 4, 2019
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy responseRajarsi Mandal, Robert M Samstein, Ken-Wing Lee, et al.Journal for Immunotherapy of Cancer|May 15, 2023
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinomaNicholas H Chakiryan, Youngchul Kim, Anders Berglund, et al.Nature Communications|December 20, 2025
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancerZiyu Chen, Xinran Tang, Jordan E Eichholz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2026
Genomic enrichment and functional impact of TP53 and CYLD alterations in recurrent and metastatic HPV-associated head and neck cancerManu Prasad, Alex T Cheng, Marcel Mayer, et al.Cell|October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with NivolumabNadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.Nature Cancer|April 9, 2021
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapyRobert M Samstein, Chirag Krishna, Xiaoxiao Ma, et al.Pageof 7